Related Experiment Video
Updated: Aug 19, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Clinical efficacy of measles vaccine during the 1990 measles epidemic
G E King1, L E Markowitz, P A Patriarca
1Division of Immunization Centers for Disease Control, Atlanta, GA.
Abstract:
Because of increased measles incidence in the United States during 1989 and 1990 and the recent finding of genomic differences between vaccine virus and contemporary wild measles viruses, we conducted a study to determine whether the current measles vaccine had become less effective. Household secondary attack rates for 203 California children ages 1 to 5 years were 4.2 and 77.8% for vaccinated and unvaccinated children, respectively, and the vaccine efficacy was 95% (95% confidence interval: 89%, 97%). The protective efficacy for postexposure vaccination and use of IG were both low, 4% (95% confidence interval: less than 0, 36%) and 8% (95% confidence interval: less than 0, 59%), respectively. The measles vaccine efficacy found in this study is similar to those obtained in previous years and indicates that the measles epidemic of 1989 to 1990 occurred despite high vaccine effectiveness.
Insights
The current measles vaccine remains highly effective, demonstrating 95% efficacy in a 1989-1990 study. This indicates the measles epidemic occurred despite the vaccine
Area of Science:
- Pediatric infectious diseases
- Vaccinology
- Epidemiology
Background:
- Increased measles incidence in the U.S. during 1989-1990.
- Genomic differences observed between vaccine and wild measles viruses.
- Need to reassess current measles vaccine effectiveness.
Purpose of the Study:
- Determine if the current measles vaccine had become less effective.
- Evaluate measles vaccine efficacy in young children.
- Assess effectiveness of postexposure interventions.
Main Methods:
- Household secondary attack rate study.
- Involved 203 California children aged 1-5 years.
- Compared vaccinated and unvaccinated children.
Main Results:
- Vaccine efficacy was 95% (95% CI: 89%-97%).
- Secondary attack rates were 4.2% for vaccinated and 77.8% for unvaccinated children.
- Low protective efficacy for postexposure vaccination (4%) and Immune Globulin (8%).
Conclusions:
- Current measles vaccine efficacy is similar to previous years.
- High vaccine effectiveness did not prevent the 1989-1990 measles epidemic.
- Measles outbreaks can occur despite high vaccine coverage.
Related Concept Videos
Vaccinations
Microorganisms in Medicine and Therapeutics
Smallpox
Chickenpox
Poliomyelitis
Respiratory Syncytial Virus Disease

